SYNLAB
Founded Year
1998Stage
IPO | IPOTotal Raised
$265MDate of IPO
4/28/2021Market Cap
2.18BStock Price
9.53Revenue
$0000About SYNLAB
SYNLAB is a provider of medical laboratory services for practicing doctors, clinics, and the pharmaceutical industry in Europe. The company offers a full range of laboratory analysis for human and veterinary medicine as well as the environment. In addition to Germany, it has branches in other European countries as well as Turkey, Saudi Arabia, and Dubai.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
SYNLAB Patents
SYNLAB has filed 2 patents.
The 3 most popular patent topics include:
- Calcium channel blockers
- Kidney diseases
- Medical terminology
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/16/2014 | Kidney diseases, Nephrology, Autoimmune diseases, Organ failure, Inflammations | Application |
Application Date | 1/16/2014 |
|---|---|
Grant Date | |
Title | |
Related Topics | Kidney diseases, Nephrology, Autoimmune diseases, Organ failure, Inflammations |
Status | Application |
Latest SYNLAB News
Aug 25, 2023
(marketscreener.com) Analyst Jan Koch from Deutsche Bank research considers the stock attractive and recommends it with a Buy rating. The target price is unchanged and still at EUR 12.https://www.marketscreener.com/quote/stock/SYNLAB-AG-122231176/news/SYNLAB-Deutsche-Bank-keeps-its-Buy-rating-44698066/?utm_medium=RSS&utm_content=20230825
SYNLAB Frequently Asked Questions (FAQ)
When was SYNLAB founded?
SYNLAB was founded in 1998.
Where is SYNLAB's headquarters?
SYNLAB's headquarters is located at Moosacher Strasse 88, Munich.
What is SYNLAB's latest funding round?
SYNLAB's latest funding round is IPO.
How much did SYNLAB raise?
SYNLAB raised a total of $265M.
Who are the investors of SYNLAB?
Investors of SYNLAB include Novo Holdings, Cinven and BC Partners.
Who are SYNLAB's competitors?
Competitors of SYNLAB include Cyted.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Compare SYNLAB to Competitors
Cyted develops digital diagnostic infrastructure helping earlier detection of stage cancer. It utilizes artificial intelligence (AI) and biomarkers to help improve patient outcomes through monitoring and analytics. The company was founded in 2020 and is based in Cambridge, United Kingdom.
LabCorp (NYSE: LH) provides medical laboratory tests and services through a national network of primary clinical laboratories. It caters to physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies. The firm was founded in 1995 and is based in Burlington, North Carolina.
Unilabs is a European supplier of laboratory and radiology services to private and public health care units, government bodies, insurance companies, the general public and to parts of the pharmaceutical industry. It covers the full spectrum of diagnostics across laboratory, imaging and pathology services at scale and operates in twelve countries in Europe. It is based in Geneva, Switzerland. On December 3rd, 2021, Unilabs was acquired by AP Moller Holding. The terms of the transaction were not disclosed.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
